Protherics PLC
Total Voting Rights and Share Capital
London, UK; Brentwood, TN; 2 October 2008 - In conformity with the
Transparency Directive, Protherics PLC ("Protherics"), the
international biopharmaceutical company focused on critical care and
cancer, notifies the market of the following:
Protherics' issued share capital consists of
342,450,241 ordinary shares with a nominal value of 2 pence each, with
voting rights. Protherics does not hold any ordinary shares in
Treasury. Therefore, the total number of voting rights
in Protherics is 342,450,241.
The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest
in, Protherics under the Financial Services Authority's Disclosure and
Transparency Rules.
/ Ends /
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com